S. Libertini
发表
R. Wenger,
K. Nolan,
W. Qi,
2019,
Kidney international.
P. Chieffi,
A. Fusco,
G. Troncone,
2004
.
P. Chieffi,
G. Botta,
G. Portella,
2011,
Endocrine-related cancer.
P. Chieffi,
G. Botta,
G. Portella,
2011
.
R. Franco,
P. Chieffi,
F. Esposito,
2009,
Journal of cellular physiology.
P. Chieffi,
G. Troncone,
G. Portella,
2004,
The Journal of endocrinology.
G. Botta,
G. Perruolo,
P. Formisano,
2010,
Human gene therapy.
A. Fusco,
M. Salvatore,
G. Portella,
2003,
The Journal of clinical endocrinology and metabolism.
H. Clevers,
S. Karlsson,
G. Sapkota,
2016
.
T. Maclachlan,
C. Herberts,
G. Gowing,
2019,
Cytotherapy.
D. Theil,
S. Libertini,
H. Martus,
2018,
Environmental and molecular mutagenesis.
R. Franco,
C. Ieranò,
S. Scala,
2008,
Clinical Cancer Research.
O. Sansom,
D. Gillespie,
S. Yamashiro,
2013,
Development.
G. Botta,
P. Formisano,
F. Beguinot,
2012,
Human gene therapy.
D. Gillespie,
N. Xu,
Y. Lao,
2012,
Oncogene.
Cdk phosphorylation of Chk1 regulates efficient Chk1 activation and multiple checkpoint proficiency.
D. Gillespie,
Yaou Zhang,
N. Xu,
2011,
Biochemical and biophysical research communications.
G. Botta,
D. Gillespie,
G. Portella,
2013,
Endocrine-related cancer.
P. Couttet,
J. Perner,
T. Doll,
2022,
Cytotherapy.
P. Chieffi,
G. de Rosa,
S. Staibano,
2006,
The Prostate.
G. Botta,
G. Portella,
S. Libertini,
2010,
Recent patents on anti-cancer drug discovery.
H. Clevers,
S. Karlsson,
G. Sapkota,
2016,
Nature Communications.
A. Odermatt,
G. Kerr,
U. Naumann,
2021,
Molecular therapy. Methods & clinical development.
O. Sansom,
D. Gillespie,
L. Tho,
2012,
Oncogene.
G. Botta,
G. Perruolo,
D. Gillespie,
2015,
Molecular oncology.
A. Fusco,
M. Vitale,
G. Portella,
2007,
Endocrinology.
G. Troncone,
F. Oriente,
G. Perruolo,
2005,
Oncogene.
P. Chieffi,
A. Fusco,
G. Troncone,
2005,
The Journal of clinical endocrinology and metabolism.
G. Botta,
D. Gillespie,
G. Portella,
2015,
Molecular oncology.
O. Sansom,
D. Gillespie,
S. Yamashiro,
2013,
Development.